Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ACGJOTCMKTS:ACNVNASDAQ:ACONWOTCMKTS:CTHZ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACGJACI Global$0.00$0.00▼$0.00N/A2.12N/AN/AACNVAccelera Innovations$0.00$0.00▼$0.00N/AN/AN/AN/AACONWAclarion$0.03$0.03$0.01▼$0.24N/AN/A39,737 shs751 shsCTHZCancer Treatment$0.00$0.00▼$0.00N/A-2.376,856 shsN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACGJACI Global0.00%0.00%0.00%0.00%-98.00%ACNVAccelera Innovations0.00%0.00%0.00%0.00%0.00%ACONWAclarion0.00%-13.55%+5.63%-32.42%-10.89%CTHZCancer Treatment0.00%0.00%0.00%0.00%-99.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACGJACI GlobalN/AN/AN/AN/AN/AN/AN/AN/AACNVAccelera InnovationsN/AN/AN/AN/AN/AN/AN/AN/AACONWAclarionN/AN/AN/AN/AN/AN/AN/AN/ACTHZCancer TreatmentN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACGJACI Global 0.00N/AN/AN/AACNVAccelera Innovations 0.00N/AN/AN/AACONWAclarion 0.00N/AN/AN/ACTHZCancer Treatment 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACGJACI GlobalN/AN/AN/AN/AN/AN/AACNVAccelera InnovationsN/AN/AN/AN/AN/AN/AACONWAclarion$54.60KN/AN/AN/AN/AN/ACTHZCancer TreatmentN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACGJACI GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/AACNVAccelera InnovationsN/AN/A0.00N/AN/AN/AN/AN/AN/AACONWAclarionN/AN/A0.00∞N/AN/AN/AN/AN/ACTHZCancer TreatmentN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACGJACI GlobalN/AN/AN/AN/AN/AACNVAccelera InnovationsN/AN/AN/AN/AN/AACONWAclarionN/AN/AN/AN/AN/ACTHZCancer TreatmentN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACGJACI GlobalN/AACNVAccelera InnovationsN/AACONWAclarionN/ACTHZCancer TreatmentN/AInsider OwnershipCompanyInsider OwnershipACGJACI Global25.94%ACNVAccelera InnovationsN/AACONWAclarionN/ACTHZCancer Treatment56.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACGJACI GlobalN/AN/AN/ANot OptionableACNVAccelera Innovations4N/AN/ANot OptionableACONWAclarion7N/AN/ANot OptionableCTHZCancer TreatmentN/AN/AN/ANot OptionableCTHZ, ACNV, ACGJ, and ACONW HeadlinesRecent News About These Companies3 Top Cancer Treatment Stocks to Buy NowJuly 17, 2024 | investorplace.comEli Gold battling ‘treatable’ form of cancerJanuary 6, 2023 | msn.comResearch Reveals The Mental Health Toll Cancer Can Take On A Patient's SpouseJanuary 6, 2023 | msn.comFormer smoker, stage 4 cancer survivor urges people to quit lighting upJanuary 6, 2023 | cbsnews.comCaring Cancer Clinicians Make All the DifferenceJanuary 6, 2023 | curetoday.comCFirst Patient Receives Keytruda Combination in Ovarian Cancer TrialJanuary 6, 2023 | curetoday.comCPele No Longer Responding to Cancer Treatment, Now under Palliative CareJanuary 5, 2023 | thisdaylive.comTColon cancer disparities: Black patients more likely to need emergency surgeryJanuary 5, 2023 | wfmynews2.comWDevon Still was afraid to have more kids after daughter’s cancer. He’s now a dad of 3January 5, 2023 | today.comTPa. Sen. Casey has cancer that’s highly curable, yet subject of debate over benefits of screeningJanuary 5, 2023 | pennlive.comPC2i Genomics extends collaboration with AstraZeneca following successful solid cancer testingJanuary 5, 2023 | outsourcing-pharma.comOParker McCollum Hands Over His Mic to a 9-Year-Old Fan Who’s Beating Cancer [Watch]January 5, 2023 | tasteofcountry.comTWith 8.0% CAGR, Liver Cancer Diagnostics Market to Hit US$ 15,951.77 million by 2028 – Exclusive Research by The Insight PartnersJanuary 5, 2023 | medgadget.comPhysicists model cell migration to learn how cancer cells navigate tissueJanuary 5, 2023 | phys.orgPProtein variant in human cells could transform breast cancer treatment, say scientistsJanuary 5, 2023 | msn.comBlood cancer drug succeeds in late-stage study, company saysJanuary 5, 2023 | wtkr.comWOU, Norman Regional to bring 'highest level' of cancer care to NormanJanuary 4, 2023 | normantranscript.comNScientists at Brigham and Women's Hospital are using cancer to fight cancerJanuary 4, 2023 | msn.comThis Full-Moon-in-Cancer Limpia Will Honor All Your EmotionsJanuary 4, 2023 | msn.comWhat January's full moon in Cancer means for you and your signJanuary 4, 2023 | news.yahoo.comMedia Sentiment Over TimeCTHZ, ACNV, ACGJ, and ACONW Company DescriptionsACI Global OTCMKTS:ACGJACI Global Corporation, a development stage company, through its subsidiaries, engages in the design and development of proprietary technology for the production of synthetic rubber powder and thermoplastic elastomers under Micropowder trade name in the United States. It intends to utilize Micropowder technology in its chemical composition and for the manufacture of rubber and elastomers that are used in tire plastic industries. ACI Global was founded in 1997 and is based in Greenwich, Connecticut.Accelera Innovations OTCMKTS:ACNVAccelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. The company's Accelera Technology, an Internet-based software platform enhances the functionality and performance of healthcare services through making clinical healthcare data available to healthcare consumers. It also provides billing, practice management, and administrative services to doctors and other clinicians, as well as home health services to patients in Chicago. The company was formerly known as Accelerated Acquisitions IV, Inc. and changed its name to Accelera Innovations, Inc. in October 2011. Accelera Innovations, Inc. was founded in 2008 and is based in Colorado Springs, Colorado.Aclarion NASDAQ:ACONW$0.03 0.00 (0.00%) As of 07/3/2025Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.Cancer Treatment OTCMKTS:CTHZCancer Treatment Holdings, Inc., through its subsidiaries, engages in providing IT-enabled services; the exploitation of an invention related to the on-site production of chlorine gas and related compounds; and providing radiation therapy, diagnostic imaging, and other medical related services. The company, through a 50% interest in a joint venture, offers IT-enabled services, including medical transcriptions, billing and collecting, bookkeeping, and claims processing services. The company enables users to manufacture chlorine on-site and when needed through its device. It has a 51% interest in a radiation therapy center located in Logan, West Virginia. In addition, through its wholly owned subsidiary, CTI Management Corp., the company's president provides management services. The company was incorporated in 1986 and is based in Carson City, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
